(Q44437034)

3 December 2017

Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidity (English)

1 reference

3 December 2017

Charani Ranasinghe

1

1 reference

PubMed ID

19582753

3 December 2017

Ian A Ramshaw

series ordinal

2

1 reference

PubMed ID

19582753

3 December 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

European Journal of Immunology

3 December 2017

1 reference

3 December 2017

39

1 reference

3 December 2017

1819-1830

1 reference

3 December 2017

7

1 reference

A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1.

3 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

High-avidity CD8+ T cells: optimal soldiers in the war against viruses and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

A single peripheral CD8+ T cell can give rise to progeny expressing type 1 and/or type 2 cytokine genes and can retain its multipotentiality through many cell divisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Profiling the CD8low phenotype, an alternative career choice for CD8 T cells during primary differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Cell-autonomous CCL5 transcription by memory CD8 T cells is regulated by IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

IL-4 and IL-13 receptors: are they one and the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Essential role of Stat6 in IL-4 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

IL-4 induces a wide-spectrum intracellular signaling cascade in CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Differential Functional Avidity of Dengue Virus-Specific T-Cell Clones for Variant Peptides Representing Heterologous and Previously Encountered Serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

A PCR primer bank for quantitative gene expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Cutting Edge: Immediate RANTES Secretion by Resting Memory CD8 T Cells Following Antigenic Stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

inferred from DOI database lookup

7 January 2021

based on heuristic

RANTES potentiates antigen-specific mucosal immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

inferred from DOI database lookup

7 January 2021

based on heuristic

Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838995

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/EJI.200838995

1 reference

3 December 2017

1 reference

PubMed ID

19582753